FI103279B1 - Förfarande för framställning av terapeutiskt användbara fosfolipid- eller lipidbundna glykosaminoglykanföreningar - Google Patents
Förfarande för framställning av terapeutiskt användbara fosfolipid- eller lipidbundna glykosaminoglykanföreningarInfo
- Publication number
- FI103279B1 FI103279B1 FI920717A FI920717A FI103279B1 FI 103279 B1 FI103279 B1 FI 103279B1 FI 920717 A FI920717 A FI 920717A FI 920717 A FI920717 A FI 920717A FI 103279 B1 FI103279 B1 FI 103279B1
- Authority
- FI
- Finland
- Prior art keywords
- lipid
- phospholipid
- derivative
- glycosaminoglycan
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2193817A JP2997018B2 (ja) | 1990-07-24 | 1990-07-24 | 燐脂質又は脂質結合グリコサミノグリカン |
JP19381690 | 1990-07-24 | ||
JP19381890 | 1990-07-24 | ||
JP19381790 | 1990-07-24 | ||
JP2193816A JP2986518B2 (ja) | 1990-07-24 | 1990-07-24 | 癌転移抑制剤 |
JP2193818A JP2986519B2 (ja) | 1990-07-24 | 1990-07-24 | 燐脂質結合グリコサミノグリカン |
JP9100995 | 1991-07-24 | ||
PCT/JP1991/000995 WO1992001720A1 (en) | 1990-07-24 | 1991-07-24 | Phospholipid- or lipid-combining glycosaminoglycan, production thereof, and cancer metastasis inhibitor |
Publications (3)
Publication Number | Publication Date |
---|---|
FI920717A0 FI920717A0 (fi) | 1992-02-19 |
FI103279B1 true FI103279B1 (sv) | 1999-05-31 |
FI103279B FI103279B (sv) | 1999-05-31 |
Family
ID=27326820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI920717A FI103279B (sv) | 1990-07-24 | 1992-02-19 | Förfarande för framställning av terapeutiskt användbara fosfolipid- el ler lipidbundna glykosaminoglykanföreningar |
Country Status (10)
Country | Link |
---|---|
US (1) | US5464942A (sv) |
EP (1) | EP0493622B1 (sv) |
KR (1) | KR0181295B1 (sv) |
AT (1) | ATE148713T1 (sv) |
AU (1) | AU647814B2 (sv) |
CA (1) | CA2067211C (sv) |
DE (1) | DE69124590T2 (sv) |
FI (1) | FI103279B (sv) |
NO (1) | NO305368B1 (sv) |
WO (1) | WO1992001720A1 (sv) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3199405B2 (ja) * | 1991-08-30 | 2001-08-20 | 生化学工業株式会社 | 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法 |
IT1260137B (it) * | 1992-04-17 | 1996-03-28 | Alfa Wassermann Spa | Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato |
WO1994001131A1 (en) * | 1992-07-13 | 1994-01-20 | Eukarion, Inc. | Transvascular and intracellular delivery of lipidized proteins |
JP3714683B2 (ja) * | 1992-07-30 | 2005-11-09 | 生化学工業株式会社 | 抗リウマチ剤 |
JP2787279B2 (ja) * | 1994-05-17 | 1998-08-13 | 雪印乳業株式会社 | 糖リン脂質及びその調製法 |
US6228998B1 (en) | 1994-07-22 | 2001-05-08 | Seikagaku Kogyo Kabushiki Kaisha | Amino spacered glycosaminoglycan derivatives and their use in copolymerization with acrylamide |
FR2725622A1 (fr) * | 1994-10-14 | 1996-04-19 | Fabre Pierre Dermo Cosmetique | Ceramide greffee anti-elastase |
CA2175282A1 (en) * | 1996-04-29 | 1997-10-30 | Rudolf Edgar Falk | Use of forms of hyaluronic acid (ha) for the treatment of cancer |
AU2602200A (en) * | 1999-01-08 | 2000-07-24 | Board Of Trustees Of The University Of Arkansas, The | Synthetic, highly charged molecules and uses thereof |
JP3032824B1 (ja) * | 1999-01-28 | 2000-04-17 | 東京医科歯科大学長 | 骨誘導促進剤 |
JP4754137B2 (ja) * | 1999-08-10 | 2011-08-24 | 生化学工業株式会社 | グリコサミノグリカン誘導体およびその使用 |
US7893226B2 (en) | 2004-09-29 | 2011-02-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
US7141552B2 (en) * | 2000-01-10 | 2006-11-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
US7811999B2 (en) * | 2000-01-10 | 2010-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
US7393938B2 (en) * | 2000-01-10 | 2008-07-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
US8076312B2 (en) * | 2000-01-10 | 2011-12-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Use of lipid conjugates in the treatment of disease |
US7772196B2 (en) * | 2000-01-10 | 2010-08-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
US20090325876A1 (en) * | 2004-09-29 | 2009-12-31 | Saul Yedgar | Use of lipid conjugates in the treatment of diseases associated with vasculature |
US9040078B2 (en) * | 2000-01-10 | 2015-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases of the nervous system |
US8304395B2 (en) * | 2000-01-10 | 2012-11-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Lipid conjugates in the treatment of disease |
US7504384B2 (en) * | 2000-01-10 | 2009-03-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of infection |
US8916539B2 (en) * | 2000-01-10 | 2014-12-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
US7608598B2 (en) | 2000-01-10 | 2009-10-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of conjunctivitis |
US8501701B2 (en) * | 2000-01-10 | 2013-08-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Use of lipid conjugates in the treatment of disease |
US7101859B2 (en) * | 2000-01-10 | 2006-09-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
US7259152B2 (en) | 2000-06-07 | 2007-08-21 | Alfa Wasserman, Inc. | Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
US8883761B2 (en) * | 2001-01-10 | 2014-11-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases associated with vasculature |
US20070185052A1 (en) * | 2005-08-03 | 2007-08-09 | Saul Yedgar | Use of lipid conjugates in cystic fibrosis and applications thereof |
US7280612B2 (en) * | 2003-07-25 | 2007-10-09 | Zarbana Digital Fund Llc | Digital branch calibrator for an RF transmitter |
EP1681306B1 (en) * | 2003-10-29 | 2013-02-20 | Teijin Limited | Hyaluronic acid compound, hydrogel thereof and material for treating joint |
JP4744973B2 (ja) * | 2005-08-05 | 2011-08-10 | 株式会社トプコン | 眼底カメラ |
US8475694B2 (en) | 2005-10-25 | 2013-07-02 | Zephyros, Inc. | Shaped expandable material |
US8859524B2 (en) | 2005-11-17 | 2014-10-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of chronic rhinosinusitis |
US8906882B2 (en) | 2005-11-17 | 2014-12-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of allergic rhinitis |
US20080183282A1 (en) * | 2006-03-09 | 2008-07-31 | Saul Yedgar | Use of lipid conjugates for the coating of stents and catheters |
CA2705785A1 (en) * | 2006-11-14 | 2008-05-22 | Saul Yedgar | Use of lipid conjugates in the treatment of diseases or disorders of the eye |
WO2008059502A2 (en) * | 2006-11-14 | 2008-05-22 | Yissum Research Development Company | Contact lens compositions |
AU2010247814B2 (en) * | 2009-05-11 | 2015-08-13 | Celsus Therapeutics Plc | Lipid-polymer conjugates, their preparation and uses thereof |
GB0916205D0 (en) | 2009-09-15 | 2009-10-28 | Zephyros Inc | Improvements in or relating to cavity filling |
US20130012473A1 (en) * | 2010-03-17 | 2013-01-10 | Ktb Tumorforschungsgesellschaft Mbh | Combined use of phospholipid and sulfate groups-carrying polysaccharides for inhibiting metastatic spread |
CA2703532C (en) * | 2010-05-10 | 2018-05-01 | Eva Turley | Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications |
CA3132335A1 (en) * | 2019-04-29 | 2020-11-05 | Alok Kumar Awasthi | Glycophospholipid polymeric network and use thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2374910A1 (fr) * | 1976-10-23 | 1978-07-21 | Choay Sa | Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations |
FR2492259A1 (fr) * | 1980-10-21 | 1982-04-23 | Idinvex Sa | Formulation d'heparine |
US4362737A (en) * | 1981-04-13 | 1982-12-07 | Schaefer Rolf | Transdermal carrier materials |
US4604376A (en) * | 1982-04-21 | 1986-08-05 | Research Corporation | Enteric compounds and complexes |
US4654327A (en) * | 1982-04-21 | 1987-03-31 | Research Corp. | Quaternary ammonium complexes of heparin |
CA1226816A (en) * | 1982-12-20 | 1987-09-15 | Moses J. Folkman | Inhibition of angiogenesis |
JPS6117A (ja) * | 1984-06-11 | 1986-01-06 | Seikagaku Kogyo Co Ltd | ムコ多糖系癌転移抑制剤 |
US5122450A (en) * | 1985-10-24 | 1992-06-16 | Research Corporation Limited | Biochemical reagent |
IL79255A0 (en) * | 1986-06-26 | 1986-09-30 | Hadassah Med Org | Composition for metastasis prevention |
IT1203515B (it) * | 1987-02-26 | 1989-02-15 | Indena Spa | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono |
WO1989008499A1 (en) * | 1988-03-17 | 1989-09-21 | Nippon Fine Chemical Co., Ltd. | Liposome |
JPH0219393A (ja) * | 1988-07-08 | 1990-01-23 | Higeta Shoyu Kk | N‐アセチルガラクトサミノオリゴ糖及びその製造方法 |
JPH0258501A (ja) * | 1988-08-25 | 1990-02-27 | Mitsubishi Gas Chem Co Inc | リポ多糖およびその用途 |
JPH03220201A (ja) * | 1988-11-18 | 1991-09-27 | Eisai Co Ltd | プロスタグランジン類と多糖類の結合体 |
-
1991
- 1991-07-24 EP EP91913108A patent/EP0493622B1/en not_active Expired - Lifetime
- 1991-07-24 KR KR1019920700665A patent/KR0181295B1/ko not_active IP Right Cessation
- 1991-07-24 WO PCT/JP1991/000995 patent/WO1992001720A1/ja active IP Right Grant
- 1991-07-24 AT AT91913108T patent/ATE148713T1/de not_active IP Right Cessation
- 1991-07-24 US US07/847,065 patent/US5464942A/en not_active Expired - Lifetime
- 1991-07-24 DE DE69124590T patent/DE69124590T2/de not_active Expired - Fee Related
- 1991-07-24 AU AU82266/91A patent/AU647814B2/en not_active Ceased
- 1991-07-24 CA CA002067211A patent/CA2067211C/en not_active Expired - Fee Related
-
1992
- 1992-02-19 FI FI920717A patent/FI103279B/sv active
- 1992-03-19 NO NO921083A patent/NO305368B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0493622A1 (en) | 1992-07-08 |
NO305368B1 (no) | 1999-05-18 |
NO921083L (no) | 1992-05-21 |
DE69124590D1 (de) | 1997-03-20 |
EP0493622B1 (en) | 1997-02-05 |
ATE148713T1 (de) | 1997-02-15 |
FI920717A0 (fi) | 1992-02-19 |
KR920702377A (ko) | 1992-09-03 |
DE69124590T2 (de) | 1997-06-12 |
US5464942A (en) | 1995-11-07 |
EP0493622A4 (en) | 1993-10-27 |
NO921083D0 (no) | 1992-03-19 |
AU647814B2 (en) | 1994-03-31 |
CA2067211C (en) | 2004-06-15 |
FI103279B (sv) | 1999-05-31 |
WO1992001720A1 (en) | 1992-02-06 |
AU8226691A (en) | 1992-02-18 |
KR0181295B1 (ko) | 1999-04-01 |
CA2067211A1 (en) | 1992-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI103279B1 (sv) | Förfarande för framställning av terapeutiskt användbara fosfolipid- eller lipidbundna glykosaminoglykanföreningar | |
NO180718C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater | |
ES8301925A1 (es) | Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico | |
ATE204875T1 (de) | Fungizide tetrahydrofurane | |
ES2186013T3 (es) | Nitratos organicos con actividad antitrombotica. | |
ATE306261T1 (de) | Antithrombosemittel | |
ATE42303T1 (de) | Herstellung von nukleosiden. | |
KR830007622A (ko) | 이소퀴놀린 유도체의 제조방법 | |
NZ240632A (en) | Purification of an ester mixture by reacting carbonyl compounds therein with an aqueous amino compound to form water-soluble products, followed by distillation | |
ES8703460A1 (es) | Un procedimiento para preparar aminoacil-ladanos | |
DE69315827D1 (de) | Neue acylierte phospholipid-arzneimittel | |
DE69629474D1 (de) | Antifungale tetrahydrofurane | |
TR200000196T2 (tr) | Avermektin bileşiklerinin üretimi. | |
PT89492A (pt) | Processo de preparacao de novos derivados de tioformamida terapeuticamente activos | |
UA26443A (uk) | Похідhі 20,21-диhоребурhамеhіhу, їх рацемати або оптичhі ізомери, або їх адитивhі солі з оргаhічhими кислотами, що мають hоотропhі та аhтидепресивhі властивості | |
FR2378518A1 (fr) | Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne | |
PT846111E (pt) | Sintese de compostos opticamente puros uteis como inibidores da garft e seus intermediarios | |
HU911945D0 (en) | Process for the production of intermediers of anti dopamin-betha-hydroxylase | |
ES2174840T3 (es) | Sales de un derivado de glucopiranosa y productos intermedios. | |
DE69634203D1 (de) | Cis-9,10-octadecenoamidase | |
FR2564463B1 (fr) | Nouveaux derives heterocycliques, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase | |
ES2018745A6 (es) | Procedimiento para la obtencion de n-carboximetilglicina y sus sales. | |
FI851073L (fi) | Inhibitor foer dopamin- -hydroxylas. | |
JPS5598177A (en) | Novel 3-hydroxyphthalide derivative |